Background It is unknown why some cases of Barrett's esophagus progress to invasive
malignant disease rapidly while others do so more slowly or not at all. The aim of this study …

AIM To clarify risk based upon segment length, diagnostic histological findings, patient age
and year of surveillance, duration of surveillance and gender. METHODS Patients registered …

Studies show Barrett's esophagus prevalence increases with age, while mean length of
Barrett's esophagus is unchanged. Few data are available about the relationship between …

OBJECTIVE: Identificating factors associated with an increased risk for dysplasia and cancer
development among patients with Barrett esophagus would aid better patient care and …

OBJECTIVES: Patients with Barrett's esophagus (BE) have an increased risk of developing
esophageal adenocarcinoma (EAC). As the absolute risk remains low, there is a need for …

Abstract Background and Aims: Surveillance endoscopy has been advocated for patients
with Barrett's esophagus but the cost‐effectiveness of this has been questioned. The aim of …

Background & Aims: The exact incidence of adenocarcinoma in patients with Barrett's
esophagus (BE) is not known and is reported to vary from 0.2%–2% per year. Published …

Background & Aims It is not clear whether length of Barrett's esophagus (BE) is a risk factor
for high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) in patients with …

Background & Aims A system is needed to determine the risk of patients with Barrett's
esophagus for progression to high-grade dysplasia (HGD) and esophageal …

Abstract Background and Aim Barrett's esophagus is associated with increased risk of
esophageal adenocarcinoma. The optimal management of low‐grade dysplasia arising in …